Vetter further expands secondary packaging
Pharmaceutical service provider relies on expanded capacities, modular production and modern analytics...
List view / Grid view
News
Top current pharmaceutical outsourcing trends
Most pharmaceutical companies are now outsourcing work to smaller firms, and here, European Pharmaceutical Review looks at current trends...
Chip-based device could transform spectrometry
Small spectrometry chips could be the future for materials analysis systems, optical coherent tomography in medical imaging and in optical networks...
Pharmaceutical outsourcing market forecast 2017-2025
A market report has given a complete backdrop analysis of the pharmaceutical outsourcing market, including market growth and shares...
Pharmacovigilance and drug safety outsourcing worth $207.7M by 2024
Outsourcing has become more popular with pharmaceutical companies, and has led to work being completed quicker, with less effort and cost involved...
Periostin concentration levels in asthmatics could reveal best treatment
Severe asthma sufferers could benefit from newer targeted therapies, and could be identified through levels of periostin in their airways...
Immunotherapy for metastatic or recurrent head and neck cancer
The KEYNOTE-048 study examined the use of immunotherapy with pembrolizumab rather than the standard treatment using cetuximab for head and neck cancer...
3D bioprinting technique for artificial organ tissue and arteries
A 3D bioprinting technique could, in the future, allow the creation of human tissue structures for the analysis of various diseases...
Immunotherapy success for triple-negative breast cancer
A combination of chemotherapy and immunotherapy could soon be used in NHS hospitals for triple-negative breast cancer to extend patient survival...
HER2+ breast cancers may benefit from short-course trastuzumab
A study trialling a short course of trastuzumab in HER2 positive breast cancer patients showed that it is as effective and cheaper than a longer course...
Appointment Ludo Gielen as new CEO Schoeller Allibert
We are pleased to announce the appointment of Ludo Gielen as new Chief Executive Officer of Schoeller Allibert effective 01 November 2018...
Generic drug labelling issues could finally have a solution
Dr Scott Gottlieb highlighted how brand reference drug companies voluntarily withdraw their marketing applications and stopped updating their labelling...
ACG group consolidates its multiple business and regional brands into a single new ACG identity
ACG Group is the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical industry. In five decades the company has expanded its global footprint and its scope has grown from empty hard capsule manufacturing to include equipment production, packaging, inspection, testing, research and development...
FDA announces steps to modernise drug development and improve efficiency
US FDA commissioner has announced steps to modernise the drug development process to improve efficiency and promote innovation...
Growth of medical cannabis market after approvals and clinical trials
A report has suggested that growth of medical cannabis will reach between $11.9 and $17.1 billion by 2020, and is currently around $5 to $6 billion...
